skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Attention:

The NSF Public Access Repository (PAR) system and access will be unavailable from 10:00 PM ET on Thursday, February 12 until 1:00 AM ET on Friday, February 13 due to maintenance. We apologize for the inconvenience.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: Wonder drugs and where to use them: a forecast of ivermectin's impact on malaria in Africa
A study in Burkina Faso revealed ivermectin inhibits malaria transmission by killing malaria parasites and mosquitoes. However, it is unknown what effect this drug will have on the malaria transmission intensities of the rest of sub-Saharan Africa (SSA). To address this issue, we created a mathematical model using malaria transmission data from 41 SSA countries to evaluate the antimalarial benefits of a mass drug administration (MDA) of ivermectin. To account for ivermectin's effect on malaria, we incorporate estimates of its ability to inhibit malaria transmission and kill mosquitoes. We consider scenarios where 0, 12.5 %, 25.0 %, and 50.0 % of the population receive ivermectin over five years and estimate malaria incidence averted, disability-adjusted life years saved, and the incremental cost-effectiveness ratio. Our findings show that an MDA of ivermectin to 12.5 %, 25 %, or 50 % of the population annually averts 248.7, 261.4, and 288.7 incidences per thousand people and saves 5.4, 5.7, and 6.3 disability-adjusted life years, respectively. These values indicate that an MDA of ivermectin would be cost-effective in 41, 18, and 6 countries, and very cost-effective in 22, 6, and 3 countries for the 12.5 %, 25 %, and 50 % scenarios. Altogether, our results indicate that ivermectin would prevent a substantial number of malaria incidences and save disability-adjusted life years in the majority of SSA. Therefore, an MDA of ivermectin would greatly aid in ongoing malaria control efforts and should be considered strongly as a complementary intervention to current malaria protocols.  more » « less
Award ID(s):
2052592
PAR ID:
10627293
Author(s) / Creator(s):
; ;
Publisher / Repository:
KeAi Publishing
Date Published:
Journal Name:
Infectious Disease Modelling
Volume:
10
Issue:
4
ISSN:
2468-0427
Page Range / eLocation ID:
1229 to 1237
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; ; ; ; ; ; ; et al (, Frontiers in Public Health)
    BackgroundCancer remains a major public health problem, especially in Sub-Saharan Africa (SSA) where the provision of health care is poor. This scoping review mapped evidence in the literature regarding the burden of cervical, breast and prostate cancers in SSA. MethodsWe conducted this scoping review using the Arksey and O'Malley framework, with five steps: identifying the research question; searching for relevant studies; selecting studies; charting the data; and collating, summarizing, and reporting the data. We performed all the steps independently and resolved disagreements through discussion. We used Endnote software to manage references and the Rayyan software to screen studies. ResultsWe found 138 studies that met our inclusion criteria from 2,751 studies identified through the electronic databases. The majority were retrospective studies of mostly registries and patient files (n= 77, 55.8%), followed by cross-sectional studies (n= 51, 36.9%). We included studies published from 1990 to 2021, with a sharp increase from 2010 to 2021. The quality of studies was overall satisfactory. Most studies were done in South Africa (n= 20) and Nigeria (n= 17). The majority were on cervical cancer (n= 93, 67.4%), followed by breast cancer (67, 48.6%) and the least were on prostate cancer (48, 34.8%). Concerning the burden of cancer, most reported prevalence and incidence. We also found a few studies investigating mortality, disability-adjusted life years (DALYs), and years of life lost (YLL). ConclusionsWe found many retrospective record review cross-sectional studies, mainly in South Africa and Nigeria, reporting the prevalence and incidence of cervical, breast and prostate cancer in SSA. There were a few systematic and scoping reviews. There is a scarcity of cervical, breast and prostate cancer burden studies in several SSA countries. The findings in this study can inform policy on improving the public health systems and therefore reduce cancer incidence and mortality in SSA. 
    more » « less
  2. ; ; ; ; ; ; ; ; (, PLOS Pathogens)
    Vernick, Kenneth D (Ed.)
    Avian malaria is expanding upslope with warmer temperatures and driving multiple species of Hawaiian birds towards extinction. Methods to reduce malaria transmission are urgently needed to prevent further declines. ReleasingWolbachia-infected incompatible male mosquitoes could suppress mosquito populations and releasingWolbachia-infected female mosquitoes (or both sexes) could reduce pathogen transmission if theWolbachiastrain reduced vector competence. We clearedCulex quinquefasciatusof their naturalWolbachia pipientis wPip infection and transinfected them withWolbachia wAlbB isolated fromAedes albopictus. We show thatwAlbB infection was transmitted transovarially, and demonstrate cytoplasmic incompatibility with wild-type mosquitoes infected withwPip from Oahu and Maui, Hawaii. We measured vector competence for avian malaria,Plasmodium relictum, lineage GRW4, of seven mosquito lines (two withwAlbB; three with naturalwPip infection, and two cleared ofWolbachiainfection) by allowing them to feed on canaries infected with recently collected field isolates of HawaiianP.relictum. We tested 73 groups (Ntotal= 1176) of mosquitoes forP.relictuminfection in abdomens and thoraxes 6–14 days after feeding on a range of parasitemias from 0.028% to 2.49%, as well as a smaller subset of salivary glands. We found no measurable effect ofWolbachiaon any endpoint, but strong effects of parasitemia, days post feeding, and mosquito strain on both abdomen and thorax infection prevalence. These results suggest that releasing malewAlbB-infectedC.quinquefasciatusmosquitoes could suppresswPip-infected mosquito populations, but would have little positive or negative impact on mosquito vector competence forP.relictumifwAlbB became established in local mosquito populations. More broadly, the lack ofWolbachiaeffects on vector competence we observed highlights the variable impacts of both native and transinfectedWolbachiainfections in mosquitoes. 
    more » « less
  3. ; ; ; ; ; ; ; ; ; (, PLOS Pathogens)
    Billker, Oliver (Ed.)
    Many mosquito species, including the major malaria vector Anopheles gambiae , naturally undergo multiple reproductive cycles of blood feeding, egg development and egg laying in their lifespan. Such complex mosquito behavior is regularly overlooked when mosquitoes are experimentally infected with malaria parasites, limiting our ability to accurately describe potential effects on transmission. Here, we examine how Plasmodium falciparum development and transmission potential is impacted when infected mosquitoes feed an additional time. We measured P . falciparum oocyst size and performed sporozoite time course analyses to determine the parasite’s extrinsic incubation period (EIP), i.e. the time required by parasites to reach infectious sporozoite stages, in An . gambiae females blood fed either once or twice. An additional blood feed at 3 days post infection drastically accelerates oocyst growth rates, causing earlier sporozoite accumulation in the salivary glands, thereby shortening the EIP (reduction of 2.3 ± 0.4 days). Moreover, parasite growth is further accelerated in transgenic mosquitoes with reduced reproductive capacity, which mimic genetic modifications currently proposed in population suppression gene drives. We incorporate our shortened EIP values into a measure of transmission potential, the basic reproduction number R 0 , and find the average R 0 is higher (range: 10.1%–12.1% increase) across sub-Saharan Africa than when using traditional EIP measurements. These data suggest that malaria elimination may be substantially more challenging and that younger mosquitoes or those with reduced reproductive ability may provide a larger contribution to infection than currently believed. Our findings have profound implications for current and future mosquito control interventions. 
    more » « less
  4. ; ; (, PLOS ONE)
    Dillman, Adler R. (Ed.)
    Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts of this treatment on host health or disease susceptibility. Here, we tracked the effects of early life Ivermectin treatment in Cuban tree frogs (Osteopilus septentrionalis) on growth rates, mortality, metabolically expensive organ size, and susceptibility toBatrachochytrium dendrobatidis(Bd) infection. One year after exposure, there was no effect of Ivermectin exposure on frog mass (X21= 0.904, p = 0.34), but when tracked through the exponential growth phase (~2.5 years) the Ivermectin exposed individuals had lower growth rates and were ultimately smaller (X21= 7.78,p= 0.005;X21= 5.36,p= 0.02, respectively). These results indicate that early life exposure is likely to have unintended impacts on organismal growth and potentially reproductive fitness. Additionally, we exposed frogs to Bd, a pathogenic fungus that has decimated amphibian populations globally, and found early life exposure to Ivermectin decreased disease susceptibility (disease load:X21= 17.57,p= 0.0002) and prevalence (control: 55%; Ivermectin: 22%) over 2 years after exposure. More research is needed to understand the underlying mechanism behind this phenomenon. Given that Ivermectin exposure altered disease susceptibility, proper controls should be implemented when utilizing this drug as an antiparasitic treatment in research studies. 
    more » « less
  5. ; ; ; ; ; ; ; (, Communications Medicine)
    Abstract BackgroundThe emergence of antimalarial drug resistance poses a major threat to effective malaria treatment and control. This study aims to inform policymakers and vaccine developers on the potential of an effective malaria vaccine in reducing drug-resistant infections. MethodsA compartmental model estimating cases, drug-resistant cases, and deaths averted from 2021 to 2030 with a vaccine againstPlasmodium falciparuminfection administered yearly to 1-year-olds in 42 African countries. Three vaccine efficacy (VE) scenarios and one scenario of rapidly increasing drug resistance are modeled. ResultsWhen VE is constant at 40% for 4 years and then drops to 0%, 235.7 (Uncertainty Interval [UI] 187.8–305.9) cases per 1000 children, 0.6 (UI 0.4–1.0) resistant cases per 1000, and 0.6 (UI 0.5–0.9) deaths per 1000 are averted. When VE begins at 80% and drops 20 percentage points each year, 313.9 (UI 249.8–406.6) cases per 1000, 0.9 (UI 0.6–1.3) resistant cases per 1000, and 0.9 (UI 0.6–1.2) deaths per 1000 are averted. When VE remains 40% for 10 years, 384.7 (UI 311.7–496.5) cases per 1000, 1.0 (0.7–1.6) resistant cases per 1000, and 1.1 (UI 0.8–1.5) deaths per 1000 are averted. Assuming an effective vaccine and an increase in current levels of drug resistance to 80% by 2030, 10.4 (UI 7.3–15.8) resistant cases per 1000 children are averted. ConclusionsWidespread deployment of a malaria vaccine could substantially reduce health burden in Africa. Maintaining VE longer may be more impactful than a higher initial VE that falls rapidly. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Text Encoded Conversion
  • XML
  • Save / Share this Record
  • Send to Email